EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Systemic Inflammation at the Crossroad of Major Depressive Disorder and Comorbidities: A Narrative Review

Erika Vitali iD, Nadia Cattane, Ilari D'Aprile, Giulia Petrillo, Annamaria Cattaneo

International Journal of Molecular Sciences · 25.09.2025 · 26 (19) · 9382

DOI: 10.3390/ijms26199382 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.09.2025. Verfasst von Erika Vitali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biological Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy. Hauptthemen laut MEDLINE: Major Depressive Disorder, Inflammation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was funded by the European Union-Next Generation EU-NRRP M6C2-Investment 2.1 Enhancement and strengthening of biomedical research in the NHS-PNRR…, European Union—Next Generation EU—NRRP M6C2—Investment 2.1 Enhancement and strengthening of biomedical research in the NHS—PNRR-MAD-2022-12375859.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Major Depressive Disorder (MDD) represents a global challenge due to its high prevalence worldwide. Inflammation is the most extensively studied and plausible biological pathway involved in the onset of MDD. Individuals with MDD often exhibit low-grade inflammation, characterized by immune system dysregulation and activation of pro-inflammatory pathways. Elevated inflammation is also associated with a reduced response to antidepressant therapies, suggesting that targeting inflammation could represent a promising therapeutic approach for MDD. MDD frequently co-occurs with other pathological conditions, including cardiometabolic, autoimmune, and chronic pain disorders. These comorbidities further complicate MDD treatment and contribute to reduced antidepressant efficacy. Like MDD, these disorders are characterized by a strong inflammatory component, and several cytokines and pro-inflammatory mechanisms altered in MDD are also found in these comorbid conditions. This narrative review explores inflammation as a shared biological mechanism in MDD and its most frequent comorbidities, to provide a comprehensive understanding of the interplay between inflammation and these comorbid conditions. Persistent low-grade inflammation may help explain the high rate of bidirectional co-occurrence between MDD and its comorbidities. Moreover, it may represent a target for better understanding the molecular mechanisms driving this co-occurrence, potentially contributing to the development of tailored treatment and improving antidepressants response rates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderInflammationComorbidityHumansAnti-Inflammatory AgentsAntidepressive AgentsCytokinesInflammation Mediators

Stichwörter der Autor:innen

autoimmune disorderscardiometabolic disorderschronic pain disorderscomorbiditiesinflammationmajor depressive disorder

Substanzen

Anti-Inflammatory AgentsAntidepressive AgentsCytokinesInflammation Mediators

Autor:innen und Institutionen

  • Biological Psychiatry Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, 25125 Brescia, Italy.
  • Department of Pharmacological and Biomolecular Sciences, University of Milan, 20133 Milan, Italy.

ORCID-Profile: Erika Vitali

Förderung

  • This research was funded by the European Union-Next Generation EU-NRRP M6C2-Investment 2.1 Enhancement and strengthening of biomedical research in the NHS-PNRR…
  • European Union—Next Generation EU—NRRP M6C2—Investment 2.1 Enhancement and strengthening of biomedical research in the NHS—PNRR-MAD-2022-12375859

Zitieren

APA

Vitali, E., Cattane, N., D'Aprile, I., Petrillo, G., & Cattaneo, A. (2025). Systemic Inflammation at the Crossroad of Major Depressive Disorder and Comorbidities: A Narrative Review. International Journal of Molecular Sciences, 26(19), 9382. https://doi.org/10.3390/ijms26199382

Vancouver

Vitali E, Cattane N, D'Aprile I, Petrillo G, Cattaneo A. Systemic Inflammation at the Crossroad of Major Depressive Disorder and Comorbidities: A Narrative Review. International Journal of Molecular Sciences. 2025;26(19):9382. doi:10.3390/ijms26199382

BibTeX
@article{Vitali2025,
  author = {Vitali, Erika and Cattane, Nadia and D'Aprile, Ilari and Petrillo, Giulia and Cattaneo, Annamaria},
  title = {Systemic Inflammation at the Crossroad of Major Depressive Disorder and Comorbidities: A Narrative Review},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {19},
  pages = {9382},
  doi = {10.3390/ijms26199382}
}
Kostenlos starten →